Rallybio Corp: 5%+ holders

Rallybio Corp has 18 Schedule 13D or 13G filings on record since 2026-02-17. 4 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Purpose of Transaction (Item 4)

Tpg Gp A, LLC

This Amendment amends and restates the final two paragraphs of Item 4 of the Original Schedule 13D in their entirety as set forth below: "On March 1, 2026, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") with Candid Therapeutics, Inc. ("Candid") and Farmington Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), whereby Merger Sub will merge with and into Candid, with Candid surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with the Merger Agreement, Rise Fund Rascal entered into a Support Agreement (the "Support Agreement") in favor of Candid providing, among other things, that Rise Fund Rascal (x) will vote all of its shares of Common Stock, among other things: (i) in favor of approving the Merger and related contemplated transactions, (ii) against any proposal made in opposition to, or in competition with, the Merger Agreement or the Merger and (iii) against any acquisition proposal involving a third party and (y) will not solicit or negotiate alternative acquisition proposal or inquiries in their capacities as stockholders of the Issuer. Other than as described above, none of the Reporting Persons nor, to the best knowledge of each of the Reporting Persons, without independent verification, any of the TPG GP A Officers, currently has any plans or proposals that relate to, or would result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D, although the …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-03-03; the filing has the rest

Timeline

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes